📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Iomai

1.1 - Company Overview

Iomai Logo

Iomai

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vaccines and immune system stimulants delivered via transcutaneous immunization (TCI), a novel needle-free technology that taps antigen-presenting cells in the outer layers of the skin to generate an enhanced immune response.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Iomai

GenePOC Logo

GenePOC

HQ: Canada Website
  • Description: Provider of accurate, cost-effective molecular solutions to detect pathogen genes, featuring a simple, stand-alone system for prevention and early detection of infectious diseases based on unique microfluidic technology; a privately owned member of Debiopharm Group.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenePOC company profile →
Brii Biosciences Logo

Brii Biosciences

HQ: United States Website
  • Description: Provider of innovative medicines developed to improve public health in China, focusing on treatment options and preventive measures for Hepatitis B (prevention in Asia-Pacific excluding Japan), HIV therapies, NTM lung disease (Greater China rights), MDR/XDR Gram-negative bacterial infections (with Monash University), and anxiety and depressive disorders via internally discovered programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brii Biosciences company profile →
Alverix Logo

Alverix

HQ: United States Website
  • Description: Provider of low-cost handheld reader devices with laboratory-grade accuracy and precision; partnering with diagnostic and OEM manufacturers to increase test accuracy, improve portability of existing tests, and develop new assays for use in physician offices and laboratory outreach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alverix company profile →
Antabio Logo

Antabio

HQ: France Website
  • Description: Provider of novel antibacterial resistance-breakers for drug-resistant infections, developing stand-alone inhibitors of bacterial metalloenzymes to restore antibiotic activity against critical pathogens; products include MEM-ANT3310 (meropenem + ANT3310, a serine-beta-lactamase inhibitor; targets CRAB and CRE), ANT3273 (inhaled for Pseudomonas aeruginosa), and ANT2681 (metallo β-lactamase inhibitor + meropenem for NDM CRE).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Antabio company profile →
Venatorx Pharmaceuticals Logo

Venatorx Pharmaceuticals

HQ: United States Website
  • Description: Provider of anti-infective therapies for multi-drug-resistant bacterial and viral infections, including cefepime-taniborbactam for complicated urinary tract infections and potentially hospital-acquired and ventilator-associated bacterial pneumonia; ceftibuten-ledaborbactam etzadroxil for drug-resistant Enterobacterales; and a PBP inhibitor program developing non-beta-lactam molecules.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Venatorx Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Iomai

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Iomai

2.2 - Growth funds investing in similar companies to Iomai

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Iomai

4.2 - Public trading comparable groups for Iomai

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Iomai

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Iomai

What does Iomai do?

Iomai is a provider of vaccines and immune system stimulants delivered via transcutaneous immunization (TCI), a novel needle-free technology that taps antigen-presenting cells in the outer layers of the skin to generate an enhanced immune response.

Who are Iomai's competitors?

Iomai's competitors and similar companies include GenePOC, Brii Biosciences, Alverix, Antabio, and Venatorx Pharmaceuticals.

Where is Iomai headquartered?

Iomai is headquartered in United States.

How many employees does Iomai have?

Iomai has 1,000 employees 🔒.

When was Iomai founded?

Iomai was founded in 2010 🔒.

What sector and industry vertical is Iomai in?

Iomai is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Iomai

Who are the top strategic acquirers in Iomai's sector and industry

Top strategic M&A buyers and acquirers in Iomai's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Iomai?

Top strategic M&A buyers groups and sectors for Iomai include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Iomai's sector and industry vertical

Which are the top PE firms investing in Iomai's sector and industry vertical?

Top PE firms investing in Iomai's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Iomai's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Iomai's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Iomai's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Iomai include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Iomai's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Iomai?

The key public trading comparables and valuation benchmarks for Iomai include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Iomai for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Iomai with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Iomai's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Iomai with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Iomai's' sector and industry vertical?

Access recent funding rounds and capital raises in Iomai's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Iomai